EarningsQ4 2021 Earnings Report

Eterna Therapeutics (ERNA) Q4 2021 Earnings Report

315 Followers

ERNA Q4 2021 EPS Results

Actual EPS-$36.00

Consensus EPS-$48.00

Beat/MissBeat by +$12.00

One Year Ago EPS-$191.04

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ4 2021

Date04/15/2022

TimeAfter Close

Conference CallFriday, April 15, 2022

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 14, 2023	2022 (Q4)	-2.40 / -1.24	-2.4	48.33% (+1.16)
Nov 08, 2022	2022 (Q3)	-2.20 / -2.49	-34	92.68% (+31.51)
Aug 15, 2022	2022 (Q2)	-0.13 / -0.06	-0.24	75.83% (+0.18)
Apr 15, 2022	2021 (Q4)	-48.00 / -36.00	-191.037	81.16% (+155.04)
Nov 09, 2021	2021 (Q3)	-24.00 / -510.00	-302.658	-68.51% (-207.34)
Aug 16, 2021	2021 (Q2)	- / -72.00	-416.616	82.72% (+344.62)
May 17, 2021	2021 (Q1)	- / -12.74	-16.794	24.16% (+4.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed